(19)
(11)
EP 0 918 857 A1
(12)
(43)
Date of publication:
02.06.1999
Bulletin 1999/22
(21)
Application number:
97938330.0
(22)
Date of filing:
14.08.1997
(51)
International Patent Classification (IPC):
G01N
33/
53
( . )
A61K
35/
12
( . )
A61K
48/
00
( . )
A61P
15/
00
( . )
A61P
25/
00
( . )
C07K
14/
47
( . )
C12N
1/
15
( . )
C12N
1/
21
( . )
C12N
15/
09
( . )
C12Q
1/
68
( . )
A61K
31/
7088
( . )
A61K
38/
00
( . )
A61P
1/
00
( . )
A61P
17/
00
( . )
A61P
35/
00
( . )
C07K
16/
18
( . )
C12N
1/
19
( . )
C12N
5/
10
( . )
C12N
15/
12
( . )
G01N
33/
574
( . )
(86)
International application number:
PCT/US1997/014378
(87)
International publication number:
WO 1998/006846
(
19.02.1998
Gazette 1998/07)
(84)
Designated Contracting States:
BE DE ES FR GB IT NL
(30)
Priority:
16.08.1996
US 19960689974
(71)
Applicant:
INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)
(72)
Inventors:
AU-YOUNG, Janice
Berkeley, CA 94702 (US)
HAWKINS, Phillip, R.
Mountain View, CA 94034 (US)
(74)
Representative:
Wright, Simon Mark
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)
(54)
HUMAN INDUCED TUMOR PROTEIN